Platinum-sensitive fallopian tube carcinoma

Clinical trials for Platinum-sensitive fallopian tube carcinoma explained in plain language.

Never miss a new study

Get alerted when new Platinum-sensitive fallopian tube carcinoma trials appear

Sign up with your email to follow new studies for Platinum-sensitive fallopian tube carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New drug combo shows promise for recurrent ovarian cancer

Disease control Ongoing

This phase II trial tests whether adding the immunotherapy tremelimumab to the PARP inhibitor olaparib works better than olaparib alone for women with platinum-sensitive recurrent ovarian, fallopian tube, or peritoneal cancer. About 61 participants will receive either olaparib al…

Matched conditions: PLATINUM-SENSITIVE FALLOPIAN TUBE CARCINOMA

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Aug 28, 2026 00:00 UTC

Platinum-sensitive fallopian tube carcinoma

Get alerted when new Platinum-sensitive fallopian tube carcinoma trials appear

New drug combo shows promise for recurrent ovarian cancer